Canada's Aurora Cannabis Q2 revenue beats estimates on international demand

Aurora Cannabis

Yesterday 12:44

Overview
Canada medical cannabis producer's fiscal Q2 revenue rose 9% yr/yr, beating analyst expectations
Adjusted net income for fiscal Q2 declined yr/yr
Company to be acquired by Organigram in deal expected to close January 2027

Outlook
Aurora Cannabis expects acquisition by Organigram to close in January 2027, pending approvals

Result Drivers
INTERNATIONAL MEDICAL SALES - Co said record international medical cannabis net revenue rose 44% yr/yr, mainly due to higher sales in Germany and Poland driven by increased patient demand
CANADIAN MEDICAL REIMBURSEMENT CHANGES - Co said Canadian medical cannabis net revenue fell 24% yr/yr, mainly due to changes in the federal reimbursement program effective April 1, 2026
CONSUMER CANNABIS WIND DOWN - Co said consumer cannabis net revenue dropped due to its strategic shift to focus on medical cannabis and wind down its consumer cannabis business

Company press release: ID:nBw2TRtyRa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
C$86.02 mln
C$72.17 mln (6 Analysts)
Q2 Adjusted Net Income
 
C$3.11 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Aurora Cannabis Inc. is C$7.80, about 6.7% above its November 4 closing price of C$7.31

Reuters Recommended Reads
Nov 4 - Green Thumb Q3 revenue beats estimates on retail, CPG growth
Nov 4 - Canada's Kinaxis Q3 SaaS revenue rises, lifts 2026 outlook
Nov 4 - Canada's Sun Life Q3 adjusted EPS beats estimates

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)